Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Treatment with nivolumab (Opdivo) had limited benefit in patients with multiple myeloma (MM) or non-Hodkin lymphoma (NHL) ...

The overall sentiment of these big-money traders is split between 42% bullish and 50%, bearish. Out of all of the options we uncovered, there was 1 put, for a total amount of $27,360, and 13, calls, ...

This mind-blowing study revealed how berberine lowers LDL cholesterol through a mechanism that’s completely different from ...

Unlike patients with HER2+ tumors, there is an unmet clinical need for patients with HER2-low expression cancers, which are refractory to trastuzumab. Sanofi SA has developed TPP-45142, a T-cell ...

Jade Biosciences, Inc. ( JBIO) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 2:15 PM EST ...

Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

The patient with significant bone marrow involvement had complete bone morphological remission. In this patient in which 95% ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Protein tyrosine phosphatase non-receptor type 2 ( PTPN2 ) is a tyrosine phosphatase involved in T cell receptor signal ...